Alternatively spliced tissue factor: A crippled protein in coagulation or a key player in non-haemostatic processes?

Hamostaseologie

Volumn 30, Issue 3, 2010, Pages 144-149

  Van Den Berg, Y W ^a   Versteeg, Henri H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiogenesis; Cancer; Cardiovascular disease; Integrins

Indexed keywords

ALTERNATIVELY SPLICED TISSUE FACTOR; FULL LENGTH TISSUE FACTOR; MESSENGER RNA PRECURSOR; THROMBOPLASTIN; UNCLASSIFIED DRUG; RNA PRECURSOR;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; COLORECTAL CANCER; CONGESTIVE CARDIOMYOPATHY; HUMAN; INFLAMMATION; NEOPLASM; NONHUMAN; PROTEIN FUNCTION; REVIEW; BLOOD; CARDIOVASCULAR DISEASE; GENETICS; HEMOSTASIS; PHYSIOLOGY;

ALTERNATIVE SPLICING; BLOOD COAGULATION; CARDIOVASCULAR DISEASES; HEMOSTASIS; HUMANS; NEOPLASMS; RNA PRECURSORS; THROMBOPLASTIN;

EID: 77957006117     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619043     Document Type: Review

References (39)

1. Versteeg HH, Ruf W. Emerging insights in tissue factor-dependent signaling events. Semin Thromb Hemost 2006; 32: 24-32.
2. Giesen PL, Rauch U, Bohrmann B et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-2315. (Pubitemid 29117911)
3. Ott I. Tissue factor in acute coronary syndromes. Semin Vasc Med 2003; 3: 185-192. (Pubitemid 37012744)
4. Key NS, Slungaard A, Dandelet L et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998; 91: 4216-4223. (Pubitemid 28261985)
5. Aras O, Shet A, Bach RR et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004; 103: 4545-4553. (Pubitemid 38745982)
6. Tesselaar ME, Romijn FP, Van der Linden IK et al. Microparticle- associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 2007; 5: 520-527.
7. Bogdanov VY, Balasubramanian V, Hathcock J et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9: 458-462. (Pubitemid 36460081)
8. Bogdanov VY, Kirk RI, Miller C et al. Identification and characterization of murine alternatively spliced tissue factor. J Thromb Haemost 2006; 4: 158-167.
9. Tardos JG, Eisenreich A, Deikus G et al. SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cells. J Thromb Haemost 2008; 6: 877-884. (Pubitemid 351524551)
10. Chandradas S, Deikus G, Tardos JG et al. Antagonistic roles of four SR proteins in the biosynthesis of alternatively spliced tissue factor transcripts in monocytic cells. J Leukoc Biol 2010; 87: 147-152.
11. Szotowski B, Antoniak S, Poller W et al. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005; 96: 1233-1239. (Pubitemid 40962100)
12. Eisenreich A, Bogdanov VY, Zakrzewicz A et al. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells. Circ Res 2009; 104: 589-599.
13. Eisenreich A, Malz R, Pepke W et al. Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells. Circ J 2009; 73: 1746-1752.
14. Censarek P, Bobbe A, Grandoch M et al. Alternatively spliced human tissue factor (asHTF) is not pro-coagulant. Thromb Haemost 2007; 97: 11-14. (Pubitemid 46242381)
15. Hobbs JE, Zakarija A, Cundiff DL et al. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb Res 2007; 120 (Suppl 2): S13-S21. (Pubitemid 350101769)
16. Boing AN, Hau CM, Sturk A et al. Human alternatively spliced tissue factor is not secreted and does not trigger coagulation. J Thromb Haemost 2009; 7: 1423-1426.
17. Szotowski B, Antoniak S, Rauch U. Alternatively spliced tissue factor: a previously unknown piece in the puzzle of hemostasis. Trends Cardiovasc Med 2006; 16: 177-182. (Pubitemid 43867331)
18. Mackman N. Alternatively spliced tissue factor - one cut too many? Thromb Haemost 2007; 97: 5-8.
19. Ruf W, Mueller BM. Thrombin generation and the pathogenesis of cancer. Semin Thromb Hemost 2006; 32 (Suppl 1): 61-68.
20. Rickles FR, Patierno S, Fernandez PM. Tissue factor, thrombin, and cancer. Chest 2003; 124: 58S-68S.
21. Rak J, Yu JL, Luyendyk J et al. Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res 2006; 66: 10643-10646. (Pubitemid 44876956)
22. Yu JL, May L, Lhotak V et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 2005; 105: 1734-1741. (Pubitemid 40223697)
23. Versteeg HH, Schaffner F, Kerver M et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood 2008; 111: 190-199.
24. Belting M, Dorrell MI, Sandgren S et al. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 2004; 10: 502-509. (Pubitemid 38667909)
25. Dorfleutner A, Hintermann E, Tarui T et al. Cross-talk of integrin alpha3beta1 and tissue factor in cell migration. Mol Biol Cell 2004; 15: 4416-4425. (Pubitemid 39299092)
26. Ahamed J, Versteeg HH, Kerver M et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci USA 2006; 103: 13932-13937. (Pubitemid 44452960)
27. Haas SL, Jesnowski R, Steiner M et al. Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation. World J Gastroenterol 2006; 12: 4843-4849. (Pubitemid 44323209)
28. Beuneu C, Vosters O, Movahedi B et al. Human pancreatic duct cells exert tissue factor-dependent procoagulant activity: relevance to islet transplantation. Diabetes 2004; 53: 1407-1411. (Pubitemid 38697649)
29. Yu JL, Rak JW. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost 2004; 2: 2065-2067.
30. Goldin-Lang P, Tran QV, Fichtner I et al. Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis. Oncol Rep 2008; 20: 123-128.
31. Rollin J, Regina S, Gruel Y. Tumour expression of alternatively spliced tissue factor is a prognostic marker in non-small cell lung cancer. J Thromb Haemost 2009; 8: 607-610.
32. Ribeiro FS, Simao TA, Amoedo ND et al. Evidence for increased expression of tissue factor and protease-activated receptor-1 in human esophageal cancer. Oncol Rep 2009; 21: 1599-1604.
33. Van den Berg YW, van den Hengel LG, Myers HR et al. Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc Natl Acad Sci USA 2009; 106: 19497-19502.
34. Szotowski B, Goldin-Lang P, Antoniak S et al. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy. J Am Coll Cardiol 2005; 45: 1081-1089. (Pubitemid 40432443)
35. Nilsson B, Berne C, Korsgren O. The recent finding that tissue factor is produced by the pancreatic islets constitutes a possible link between insulin resistance and cardiovascular disease. Am J Ther 2005; 12: 551-554. (Pubitemid 41689755)
36. Andrie RP, Bauriedel G, Braun P et al. Increased expression of C-reactive protein and tissue factor in acute coronary syndrome lesions: Correlation with serum C-reactive protein, angioscopic findings, and modification by statins. Atherosclerosis 2009; 202: 135-143.
37. Krupinski J, Turu MM, Font MA et al. Blood-borne tissue factor activity predicts major cerebrovascular events in patients undergoing carotid endarterectomy: results from a 1-year follow-up study. Cerebrovasc Dis 2008; 25: 32-39. (Pubitemid 351280373)
38. Virmani R, Kolodgie FD, Burke AP et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25: 2054-2061. (Pubitemid 41416300)
39. Parry GC, Erlich JH, Carmeliet P et al. Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest 1998; 101: 560-569. (Pubitemid 28084238)